Harald Hampel, MD, PhD, MA, MSc

Harald Hampel, MD, PhD, MA, MSc

Vice President, Chief Medical Officer, Eisai Inc
Verified email at med.uni-muenchen.de
Cited by 58525
Karen Bush

Karen Bush

Indiana University Bloomington
Verified email at indiana.edu
Cited by 30912
Matthew R Nelson

Matthew R Nelson

Deerfield
Verified email at deerfield.com
Cited by 9309
Michael J. Tocci

Michael J. Tocci

Associate Dean of Research, NJ Center for Science, Technology & Mathematics, Kean …
Verified email at kean.edu
Cited by 7879
SNEHASIS JANA

SNEHASIS JANA

Chief Scientific Officer, TSRL
Verified email at trivedisrl.com
Cited by 5673
Gabriel Helmlinger

Gabriel Helmlinger

Executive Director, AstraZeneca Pharmaceuticals
Verified email at astrazeneca.com
Cited by 3906
Dr. Mukul Jain

Dr. Mukul Jain

President at Zydus Research Centre, Ahmedabad, India
Verified email at zyduscadila.com
Cited by 3212
Ajith Welihinda

Ajith Welihinda

Director, Cell Biology; Head of Cell Signaling and Assay Development, Molecular Medicine …
Verified email at mmrx.org
Cited by 2360
Timothy Goggin

Timothy Goggin

RETIRED VP Clinical Pharmacology & Pharmacometrics, Otsuka,USA
Verified email at otsuka-us.com
Cited by 2232
Subrahmanyam Vangala

Subrahmanyam Vangala

CEO, ReaGene Biosciences Pvt Ltd; CEO, InCan Solutions Pvt Ltd
Verified email at incansolutions.com
Cited by 2014
1 - 10